Teladoc faces securities fraud probe after cutting 2026 revenue forecast, shares plunge 38%.
Teladoc Health announced a lowered revenue forecast for 2026, citing challenges in its cash pay model and pressures on its BetterHelp platform. Following this, its stock price dropped sharply by 38.32%. Pomerantz LLP has launched an investigation int...
